AMAT
59
4
EXPE
81
-2
COF
52
3
TXN
46
14
TJX
44
2
WBA
64
-3
FDX
36
-3
HRB
45
-2
APD
67
2
COST
57
4
RCL
61
4
SE
74
3
EQR
39
-3
CNX
52
-3
UA
41
2
EQT
57
7
ACN
54
2
MAR
48
-3
NDAQ
57
-2
T
42
3
AMAT
59
4
EXPE
81
-2
COF
52
3
TXN
46
14
TJX
44
2
WBA
64
-3
FDX
36
-3
HRB
45
-2
APD
67
2
COST
57
4
RCL
61
4
SE
74
3
EQR
39
-3
CNX
52
-3
UA
41
2
EQT
57
7
ACN
54
2
MAR
48
-3
NDAQ
57
-2
T
42
3
Financhill
Back

NovoCure Stock Price Chart

Free Access to "King of the Quants" Stock Rating System

[Claim Your 3 Free Grades Now]
Sell
32

NVCR
NovoCure

Last Price:
$26.16
Seasonality Move:
1.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Access "King of the Quants" Stock Rating System FREE!

[Claim Your 3 Free Grades Now]
  • The current trend is moderately bearish and NVCR is experiencing slight selling pressure.

NovoCure Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 27.19 Sell
20-day SMA: 29.2 Sell
50-day SMA: 25.23 Buy
200-day SMA: 19.49 Buy
8-day EMA: 27.14 Sell
20-day EMA: 27.99 Sell
50-day EMA: 25.83 Buy
200-day EMA: 21.75 Buy

NovoCure Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 41.68 Sell
Chaikin Money Flow: -348351 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.7 - 31.7) Sell
Bollinger Bands (100): (14.92 - 27.04) Buy

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for NovoCure Stock

Is NovoCure Stock a Buy?

  • NovoCure share price is 26.17 while NVCR 8-day simple moving average is 27.19, which is a Sell signal.
  • The stock price of NVCR is 26.17 while NovoCure 20-day SMA is 29.20, which makes it a Sell.
  • NovoCure 50-day simple moving average is 25.23 while NVCR share price is 26.17, making it a Buy technically.
  • NVCR stock price is 26.17 and NovoCure 200-day simple moving average is 19.49, creating a Buy signal.

NVCR Technical Analysis vs Fundamental Analysis

Sell
32
NovoCure (NVCR) is a Sell

Is NovoCure a Buy or a Sell?

  • NovoCure stock is rated a Sell
    The current NovoCure [NVCR] share price is $26.17. The Score for NVCR is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.

NovoCure Stock Info

Market Cap:
2.8B
Price in USD:
26.17
Share Volume:
1.2M

NovoCure 52-Week Range

52-Week High:
34.13
52-Week Low:
11.70
Sell
32
NovoCure (NVCR) is a Sell

NovoCure Share Price Forecast

  • What is the NovoCure stock price today?
    The NovoCure stock price is 26.17 USD today.
  • Will NVCR stock go up or go down?
    NovoCure> share price is forecast to RISE/FALL based on technical indicators
  • Is NovoCure overvalued?
    According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovoCure is overvalued.

Is NovoCure Stock a Buy?

  • NovoCure share price is 26.17 while NVCR 8-day exponential moving average is 27.14, which is a Sell signal.
  • The stock price of NVCR is 26.17 while NovoCure 20-day EMA is 27.99, which makes it a Sell.
  • NovoCure 50-day exponential moving average is 25.83 while NVCR share price is 26.17, making it a Buy technically.
  • NVCR stock price is 26.17 and NovoCure 200-day simple moving average is 21.75, creating a Buy signal.

Fundamental Analysis of NovoCure

Is NovoCure a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and a decrease next year of $0.03 per share.

Technical Analysis of NovoCure

Should I short NovoCure stock?

  • NVCR Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting NovoCure is a Sell
  • NovoCure Relative Strength Index (RSI) is 41.68, which suggest NovoCure is oversold
  • The Bollinger Bands (25) for NovoCure is (27.7 - 31.7), which suggest NovoCure is a Buy
  • The Bollinger Bands (100) for NovoCure is (14.92 - 27.04), which suggest NovoCure is a Buy

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.